Free Review Articles on Cardiovascular risk                                 Metatextbook

Freie Reviews über Kardiovaskulaeres Risikoprofil                                 Look here for Journal Homepages

  • Cardiovascular risk
  • Atherosclerosis (peripheral vessels)
  • Homocysteine
  • Testosterone
  • Heart (Atrial fibrillation)
  • Implanted cardioverter defibrillator
  • Sudden death (cardiogenic)
  • Leptin
  • Ankle arm index
  • Adiponectin
  • Isoprostane
  • Endothelial dysfunction
  • Pregnancy associated plasma protein A
  • Stroke (BASKET)
  • Atherosclerosis (Carotids and Basilaris)
  • Statin
  • Heart rate variability
  • Sleep apnea (Obstructive)
  • Aldosterone
  • Glucocorticoids
  • Acromegaly
  • Cushing s syndrome
  • Porphyromonas gingivalis
  • Periodontosis
  • Streptococcus mutans
  • Aorta and great vessels (Aneurysm)
  • Kidney (Chronic renal failure)
  • Macrophages
  • Sitosterolemia
  • Neopterin
  • Myeloperoxidase
  • Cystatin
  • Radiation damage and control
  • Caries
  • Lipoprotein a
  • Homer
  • Erectile dysfunction
  • Coronary heart disease (BASKET)
  • Sympathetic nervous system
  • Atherosclerosis (BASKET)
  • Vitamin D
  • Autoimmunity
  • Nitric oxide NO
  • TGF beta
  • Sodium (Salt)
  • Transplantation
    • Nr.Year

    OPEN

    		Titleusers

    say

    		rate

    good

    		rate

    bad

    no link

    		Citation
    12009Therapeutic implications of selecting the SCORE (European) versus the D'AGOSTINO (American) risk charts for cardiovascular risk assessment in hypertensive patients.



    		+-nlBMC Cardiovasc Disord 9(-):17 (2009)
    22007Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning.



    		+-nlPharmacol Rev 59(4):418-58 (2007)
    32009Beyond LDL cholesterol: the role of elevated triglycerides and low HDL cholesterol in residual CVD risk remaining after statin therapy.



    		+-nlAm J Manag Care 15(3 Suppl):S65-73 (2009)
    42005Conditional risk factors for atherosclerosis.



    		+-nlMayo Clin Proc 80(2):219-30 (2005)
    52008Homocysteine level and coronary heart disease incidence: a systematic review and meta-analysis.



    		+-nlMayo Clin Proc 83(11):1203-12 (2008) Humphrey LL
    62007Testosterone and cardiovascular risk in men: a systematic review and meta-analysis of randomized placebo-controlled trials.



    		+-nlMayo Clin Proc 82(1):29-39 (2007) Haddad RM
    72009Dissociation of aortic pulse wave velocity with risk factors for cardiovascular disease other than hypertension: a systematic review.



    		+-nlHypertension 54(6):1328-36 (2009) Cecelja M
    82010PLA2G7 genotype, lipoprotein-associated phospholipase A2 activity, and coronary heart disease risk in 10 494 cases and 15 624 controls of European Ancestry.



    		+-nlCirculation 121(21):2284-93 (2010)
    92009Impact of proteinuria and glomerular filtration rate on risk of thromboembolism in atrial fibrillation: the anticoagulation and risk factors in atrial fibrillation (ATRIA) study.



    		+-nlCirculation 119(10):1363-9 (2009)
    102008American Heart Association/American College of Cardiology Foundation/Heart Rhythm Society scientific statement on noninvasive risk stratification techniques for identifying patients at risk for sudden cardiac death: a scientific statement from the American Heart Association Council on Clinical Cardiology Committee on Electrocardiography and Arrhythmias and Council on Epidemiology and Prevention.



    		+-nlCirculation 118(14):1497-1518 (2008)
    112008Leptin and cardiovascular disease: response to therapeutic interventions.



    		+-nlCirculation 117(25):3238-49 (2008)
    122009The ankle-brachial index as a biomarker of cardiovascular risk: it's not just about the legs.



    		+-nlCirculation 120(21):2033-5 (2009)
    132011Chronic inflammation links cardiovascular, metabolic and renal diseases.



    		+-nlCirc J 75(12):2739-48 (2011)
    142010Role of adiponectin in cardiovascular protection.



    		+-nlCirc J 74(3):432-3 (2010) Nanasato M
    152009Obesity-related risk factors of cardiovascular disease.



    		+-nlCirc J 73(12):2204-5 (2009)
    162009Adiponectin and cardiovascular disease.



    		+-nlCirc J 73(4):608-14 (2009)
    172005Quantification of isoprostanes as indices of oxidant stress and the risk of atherosclerosis in humans.



    		+-nlArterioscler Thromb Vasc Biol 25(2):279-86 (2005)
    182003Endothelial dysfunction: a marker of atherosclerotic risk.



    		+-nlArterioscler Thromb Vasc Biol 23(2):168-75 (2003)
    192008Is LDL-C passed its prime? The emerging role of non-HDL, LDL-P, and ApoB in CHD risk assessment.



    		+-nlArterioscler Thromb Vasc Biol 28(9):1582-3 (2008) Davidson MH
    202005Sensitivity and specificity of the ankle-brachial index to predict future cardiovascular outcomes: a systematic review.



    		+-nlArterioscler Thromb Vasc Biol 25(7):1463-9 (2005)
    212007European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).



    		+-nlEur Heart J 28(19):2375-414 (2007)
    222008New cardiovascular risk factors exist, but are they clinically useful?



    		+-nlEur Heart J 29(4):441-4 (2008)
    232008New cardiovascular risk determinants do exist and are clinically useful.



    		+-nlEur Heart J 29(4):436-40 (2008)
    242006Pregnancy-associated plasma protein-A and cardiovascular risk.



    		+-nlEur Heart J 27(14):1637-9 (2006) Kaski JC
    252010Where vascular meets neurodegenerative disease.



    		+-nlStroke 41(10 Suppl):S144-6 (2010)
    262003Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review.



    		+-nlStroke 34(11):2741-8 (2003) Rashid P
    272003Relationship between blood pressure and stroke risk in patients with symptomatic carotid occlusive disease.



    		+-nlStroke 34(11):2583-90 (2003)
    282010Advances in population-based studies.



    		+-nlStroke 41(2):e99-101 (2010)
    292008Statin therapy for stroke prevention.



    		+-nlStroke 39(3):1042-8 (2008)
    302009A systematic review of angiotensin receptor blockers in preventing stroke.



    		+-nlStroke 40(12):3876-8 (2009)
    312009Clinical impact of evaluation of cardiovascular control by novel methods of heart rate dynamics.



    		+-nlPhilos Transact A Math Phys Eng Sci 367(1892):1223-38 (2009)
    322010Endocrine aspects of obstructive sleep apnea.



    		+-nlJ Clin Endocrinol Metab 95(2):483-95 (2010)
    332007Aldosterone as a cardiovascular risk hormone.



    		+-nlEndocr J 54(3):359-70 (2007)
    342010Molecular determinants of the cardiometabolic phenotype.



    		+-nlEndocr Metab Immune Disord Drug Targets 10(2):109-23 (2010)
    352007Glucocorticoids and cardiovascular disease.



    		+-nlEur J Endocrinol 157(5):545-59 (2007)
    362010Mortality in patients with pituitary disease.



    		+-nlEndocr Rev 31(3):301-42 (2010)
    372010Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Porphyromonas gingivalis is the important role of intimal hyperplasia in the aorta.



    		+-nlJ Pharmacol Sci 113(2):110-4 (2010)
    382010Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Cell-surface structures of novel serotype k Streptococcus mutans strains and their correlation to virulence.



    		+-nlJ Pharmacol Sci 113(2):120-5 (2010)
    392010Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Implication of periodontal diseases in development of systemic diseases.



    		+-nlJ Pharmacol Sci 113(2):103-9 (2010)
    402010Roles of oral bacteria in cardiovascular diseases--from molecular mechanisms to clinical cases: Involvement of Porphyromonas gingivalis in the development of human aortic aneurysm.



    		+-nlJ Pharmacol Sci 113(2):115-9 (2010)
    412011Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis.



    		+-nlPLoS One 6(10):e25920 (2011)
    422007A two-carbon switch to sterol-induced autophagic death.



    		+-nlAutophagy 3(1):38-41 (2007)
    432004Atherogenic index of plasma [log(triglycerides/HDL-cholesterol)]: theoretical and practical implications.



    		+-nlClin Chem 50(7):1113-5 (2004) Dobiasova M
    442009Neopterin and cardiovascular disease: growing evidence for a role in patient risk stratification.



    		+-nlClin Chem 55(6):1056-7 (2009)
    452009Myeloperoxidase: a useful biomarker for cardiovascular disease risk stratification?



    		+-nlClin Chem 55(8):1462-70 (2009)
    462009Cystatin C and cardiovascular risk.



    		+-nlClin Chem 55(11):1932-43 (2009)
    472011Radiation as a risk factor for cardiovascular disease.



    		+-nlAntioxid Redox Signal 15(7):1945-56 (2011)
    482003Endothelial dysfunction: a crystal ball prediction for enhanced cardiovascular risk?



    		+-nlIsr Med Assoc J 5(10):736-8 (2003) Shechter M
    492008Cardiovascular morbidity in obstructive sleep apnea: oxidative stress, inflammation, and much more.



    		+-nlAm J Respir Crit Care Med 177(4):369-75 (2008)
    502008Bacteremia originating in the oral cavity. A review.



    		+-nlMed Oral Patol Oral Cir Bucal 13(6):E355-62 (2008)
    512009Genetic variants associated with Lp(a) lipoprotein level and coronary disease.



    		+-nlN Engl J Med 361(26):2518-28 (2009)
    522004Clinical usefulness of plasma homocysteine in vascular disease.



    		+-nlMed J Aust 181(6):314-8 (2004)
    532011Preventing vascular disease - effective strategies for implementing guidelines in general practice.



    		+-nlAust Fam Physician 40(10):825-8 (2011)
    542009Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality.



    		+-nlJAMA 302(4):412-23 (2009)
    552007Erectile dysfunction: a marker of early coronary heart disease.



    		+-nlHellenic J Cardiol 48(4):185-91 (2007)
    562007Overestimation and underestimation of cardiovascular risk in clinical practice: usefulness of risk estimation charts.



    		+-nlHellenic J Cardiol 48(6):341-5 (2007)
    572008Erectile dysfunction and coronary artery disease: a relationship for disclosure.



    		+-nlHellenic J Cardiol 49(1):1-6 (2008)
    582010Cardiovascular consequences of obstructive sleep apnoea.



    		+-nlIndian J Med Res 131(-):196-205 (2010)
    592009Cardiovascular disease in obstructive sleep apnoea syndrome: the role of intermittent hypoxia and inflammation.



    		+-nlEur Respir J 33(5):1195-205 (2009)
    602007Effect of lipid-lowering and anti-hypertensive drugs on plasma homocysteine levels.



    		+-nlVasc Health Risk Manag 3(1):99-108 (2007)
    612008Measurement of endothelial function and its clinical utility for cardiovascular risk.



    		+-nlVasc Health Risk Manag 4(3):647-52 (2008)
    622009Periodontal bacteria and cardiovascular problems.



    		+-nlFuture Microbiol 4(5):495-8 (2009)
    632008Altered central catecholaminergic transmission and cardiovascular disease.



    		+-nlExp Physiol 93(6):725-40 (2008)
    642007Apo B/apo A-I ratio and cardiovascular risk prediction.



    		+-nlArq Bras Cardiol 88(6):e187-90 (2007)
    652008Risk factors for the development of atherosclerosis in childhood and adolescence.



    		+-nlArq Bras Cardiol 90(4):276-283 (2008)
    662010Role of vitamin D in cardiovascular disease.



    		+-nlNeth J Med 68(3):113-8 (2010)
    672012Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions.



    		+-nlClin Dev Immunol 2012(-):974648 (2012)
    682009The dark side of testosterone deficiency: III. Cardiovascular disease.



    		+-nlJ Androl 30(5):477-94 (2009)
    692009Far-infrared saunas for treatment of cardiovascular risk factors: summary of published evidence.



    		+-nlCan Fam Physician 55(7):691-6 (2009)
    702009Vascular consequences of dietary salt intake.



    		+-nlAm J Physiol Renal Physiol 297(2):F237-43 (2009)
    712008Cardiovascular disease in transplant recipients: current and future treatment strategies.



    		+-nlClin J Am Soc Nephrol 3 Suppl 2(-):S29-37 (2008)
    722008Emerging biomarkers for evaluating cardiovascular risk in the chronic kidney disease patient: how do new pieces fit into the uremic puzzle?



    		+-nlClin J Am Soc Nephrol 3(2):505-21 (2008)



    Downloaded from http://www.kidney.de - The Database of Free Medical Reviews - The Metatextbook of Medicine - Ossip Groth

    All data shown were primarily retrieved from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.